Rosa Bacchetta researcher
Bacchetta, Rosa
VIAF ID: 2128164661911203390002 (Personal)
Permalink: http://viaf.org/viaf/2128164661911203390002
Preferred Forms
- 100 1 _ ‡a Bacchetta, Rosa
- 100 0 _ ‡a Rosa Bacchetta ‡c researcher
4xx's: Alternate Name Forms (1)
Works
Title | Sources |
---|---|
An anti-CD45RO/RB monoclonal antibody modulates T cell responses via induction of apoptosis and generation of regulatory T cells. | |
APVO210: A Bispecific Anti-CD86-IL-10 Fusion Protein (ADAPTIR™) to Induce Antigen-Specific T Regulatory Type 1 Cells. | |
BAT2 and BAT3 polymorphisms as novel genetic risk factors for rejection after HLA-related SCT | |
Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells | |
CRISPR-based gene editing enables FOXP3 gene repair in IPEX patient cells | |
Ectopic FOXP3 Expression Preserves Primitive Features Of Human Hematopoietic Stem Cells While Impairing Functional T Cell Differentiation. | |
Human inborn errors of immunity: An expanding universe | |
Hurdles in therapy with regulatory T cells | |
Immunological Outcome in Haploidentical-HSC Transplanted Patients Treated with IL-10-Anergized Donor T Cells | |
Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. | |
Isolation, expansion, and characterization of human natural and adaptive regulatory T cells | |
Killing of myeloid APCs via HLA class I, CD2 and CD226 defines a novel mechanism of suppression by human Tr1 cells. | |
Methods for in vitro generation of human type 1 regulatory T cells | |
Minimum Information about T Regulatory Cells: A Step toward Reproducibility and Standardization. | |
Molecular and functional characterization of allogantigen-specific anergic T cells suitable for cell therapy. | |
Peanut-specific type 1 regulatory T cells induced in vitro from allergic subjects are functionally impaired. | |
Regulatory T cells: prospective for clinical application in hematopoietic stem cell transplantation. | |
STAT5-signaling cytokines regulate the expression of FOXP3 in CD4+CD25+ regulatory T cells and CD4+CD25- effector T cells. | |
Tr1 cells and the counter-regulation of immunity: natural mechanisms and therapeutic applications. | |
Tr1 cells: from discovery to their clinical application. | |
Type 1 regulatory T (Tr1) cells: from the bench to the bedside. |